CVE-2023-33365

A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
Configurations

Configuration 1 (hide)

cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*

History

09 Aug 2023, 11:34

Type Values Removed Values Added
CWE CWE-22
References (MISC) https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 - (MISC) https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 - Release Notes, Vendor Advisory
References (MISC) https://claroty.com/team82/disclosure-dashboard/cve-2023-33365 - (MISC) https://claroty.com/team82/disclosure-dashboard/cve-2023-33365 - Third Party Advisory
CPE cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*
CVSS v2 : unknown
v3 : unknown
v2 : unknown
v3 : 7.5

03 Aug 2023, 16:56

Type Values Removed Values Added
New CVE

Information

Published : 2023-08-03 16:15

Updated : 2024-02-05 00:01


NVD link : CVE-2023-33365

Mitre link : CVE-2023-33365

CVE.ORG link : CVE-2023-33365


JSON object : View

Products Affected

supremainc

  • biostar_2
CWE
CWE-22

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')